Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
johnson & johnson
astrazeneca
cancer
cancer immunotherapy
car-t immunotherapy
celgene
ceo
clinical trials
deals
drug prices
What
bio
drug
roundup
companies
nash
news
approval
approved
away
biogen’s
biopharma
biopharmaceutical
bringing
car
celgene
ceos
colleagues
convo
dc
digital
disease
earlier
epidemic
executives
exome
failures
fatty
fda
frenzied
gathered
government
groups
growing
health
hearing
held
hundreds
industry
known
led
Language
Current search:
abbvie
×
merck
×
" bristol-myers squibb "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
